Lucintel's latest study found that, The future of the global hemodialysis catheter market looks promising with opportunities in the hospital and home dialysis markets. The global hemodialysis catheter market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rise in the prevalence of end-stage renal disease, increase in the number of persons suffering from chronic renal disease, and scarcity of kidney donors for transplantation and technological advancements in dialysis equipment.

In this market, cuffed tunneled catheter, non-cuffed tunneled catheter, and non-tunneled catheter are the major segments of hemodialysis catheter market by product.

Lucintel forecasts that non-cuffed tunneled catheter will remain the largest segment over the forecast period because the catheters that are not cuffed are simpler and faster to insert, as they do not have the large cuff and in emergencies where quick vascular access is required, this can be helpful for patients with weak vasculature.

Browse in depth TOC of the Hemodialysis Catheter Market

100 - Figures

150-Pages

Hemodialysis Catheter Market is marked by presence of several big and small players. AST Products, Bayer, Biocoat, Covalon, Harland Medical Services, Hydromer, Kisco, Precision Coating, Surmodics, and Royal Dsm are the major suppliers in the hemodialysis catheter market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected].